Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNET HR+ 5: High-Risk Cerebral PNET in Children
NCT00936156Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Jan 2009
- Primary completion
- Jan 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, etoposide, thiotepa, temozolomide in medulloblastoma, supratentorial primitive neuroectodermal tumor (sPNET), sponsored by Gustave Roussy. Started Jan 2009; status: completed.
02
Drugs
carboplatinetoposidethiotepatemozolomide
03
Conditions
medulloblastomasupratentorial primitive neuroectodermal tumor (sPNET)
Beyond the preview
Go deeper on NCT00936156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936156.